23 results
Invasive Aspergillus (IA) - Diagnosis and Management
Aspergillus is ubiquitous in nature. Most invasive infections are caused
immunosuppression (eg ... allogeneic HSCT, SOT ... HSCT; sn lower in SOT ... this morphology Treatment ... Diagnosis #Management #treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment ... opportunistic #infections
Fungal Biomarkers: Beta-D-Glucan and Aspergillus Galactomannan
Beta-D-Glucan:
 • Polysaccharide cell wall component of many fungi
 • Pathogens:
invasive fungal infection ... (IFI) in hematologic ... formulations (e.g ... surfaces - Infections ... non-neutropenic pts, SOT
Autoimmune Hemolytic Anemia (AIHA) Treatment
Warm AIHA:
1) Steroids - 1-2 mg/kg prednisone daily
   • Until
Autoimmune Hemolytic Anemia ... (AIHA) Treatment ... Steroids - 1-2 mg/kg ... Polyclonal: - Infection ... #management #hematology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... in HIV-AIDS Preventing ... other factors (e.g ... Cytomegalovirus #CMV #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Coccidiodomycosis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... acyclovir 5 mg/kg ... • Continue treatment ... HerpesSimplex #HSV #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... #Cryptococcus #IDSA ... #Prevention #Treatment ... opportunistic #infections